InvestorsHub Logo
Followers 0
Posts 2177
Boards Moderated 0
Alias Born 04/13/2018

Re: None

Friday, 05/07/2021 1:23:10 PM

Friday, May 07, 2021 1:23:10 PM

Post# of 233761
You can see CYDY remains below 3 bucks despite going into "revenue next week, maybe" according to Nader.

Let's review what we know about Nader:

Nader is a pathological liar.

Nader is a habitual law breaker.

Nader is equally incompetent as he is narcissistic.



So we have that. Now let's review the drug itself.

1. Receptor Occupancy is at issue.

2. 700mg data which we supposedly have has mysteriously not been filed.

3. No trial to date has successfully shown that the drug actually works or should be approved.


But let's dig deeper into the company's playbook when it comes to accomplishing goals and seeking revenue.

1. Anytime a project nears completion or requires a formal approval. CYDY switches to another project further back of any other.

2. HIV the closest to any study in terms of approval and generating revenue has no timeline assigned and no further substantive updates from management. Literally the life line of the company is no where insight.

3. The COVID studies have all failed, and require new trials per Nader. These trials however are now being conducted mostly outside of the United States away from the eyes of a major regulatory agency.

4. Nader and CYDY is attempting to contravene international law by trying to charge a fee for compassionate use. They are trying to get away with avoiding the laws regarding the commercial sales of unapproved drugs. So you will have a US company selling an unapproved drug.

Here is what happens when a drug gets sourced to another country and ends up magically showing up in the hands of US Customers:

https://www.fda.gov/news-events/press-announcements/fda-warns-canarx-selling-unapproved-misbranded-and-unsafe-imported-drugs-unsuspecting-americans

For additional information here is how the FDA follows and deals with unapproved drug sales.

https://www.fda.gov/media/71004/download



The last time any compassionate use drug was allowed to "charge a fee" was medical cannibus but that was through a special act of their congress:

https://www.congress.gov.ph/legisdocs/third_17/HBT6517.pdf

So again a case of Nader not doing his homework or outright lying. A simple Google search would have informed him that the regulatory issues surrounding this would require more than a phone call to their FDA.

Why do I think Nader is lying and knows better. Because he is tossing maybes around like M&Ms. The same kind of stock pumping statements like the forever infamous "conditional EUA." His backtracking on that on the last Conference Call should be a dead giveaway on how he came up with "It's not commercial sales, it's a fee." Think of him explaining that before prosecutors, congress or a major regulatory body.

Nader has to go he is taking the company into legally perilous waters and putting off revenue producing projects. The man is a menace.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News